Difference between revisions of "Template:Infobox medical condition/testcases"
Jump to navigation
Jump to search
imported>Paine Ellsworth (/testcases) |
imported>Plastikspork (Remove page from Special:WantedTemplates) |
||
| (3 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
| − | |||
| − | |||
==[[Bisalbuminemia]]== | ==[[Bisalbuminemia]]== | ||
:{{q|Q4917184}} {{q|P1995}} | :{{q|Q4917184}} {{q|P1995}} | ||
| − | |||
:{{#invoke:Wikidata|getValueFromID|Q4917184|P1995|FETCH_WIKIDATA}} | :{{#invoke:Wikidata|getValueFromID|Q4917184|P1995|FETCH_WIKIDATA}} | ||
| Line 33: | Line 30: | ||
| specialty = something-with-ref<ref>{{cite web|title=Something|url=http://aaaa.com|website=AAA|accessdate=2 March 2016|date=March 1, 2011}}</ref> | | specialty = something-with-ref<ref>{{cite web|title=Something|url=http://aaaa.com|website=AAA|accessdate=2 March 2016|date=March 1, 2011}}</ref> | ||
| + | }} | ||
| + | ==[[User:lukelahood/sandbox]]== | ||
| + | {{testcase_table | ||
| + | | name = Facioscapulohumeral muscular dystrophy | ||
| + | | synonyms = Landouzy–Dejerine muscular dystrophy, FSHMD, FSH | ||
| + | | image = File:Timelapse Expression of DUX4 Protein in FSHD Cells.ogv | ||
| + | | image_thumbtime = 34 | ||
| + | | caption = Timelapse of DUX4 being expressed in FSHD Muscle Cells<ref name=DUX4expression>{{cite journal|last1=Rickard|first1=Amanda|last2=Petek|first2=Lisa|last3=Miller|first3=Daniel|title=Endogenous DUX4 expression in FSHD myotubes is sufficient to cause cell death and disrupts RNA splicing and cell migration pathways|journal=Hum. Mol. Genet.|date=August 5, 2015|doi=10.1093/hmg/ddv315|url=http://hmg.oxfordjournals.org/content/early/2015/08/17/hmg.ddv315.long|accessdate=September 10, 2015|pmid=26246499|pmc=4581613|volume=24|issue=20|pages=5901–14}}</ref> | ||
| + | | pronounce = | ||
| + | | field = [[Neurology]] | ||
| + | | symptoms = Facial weakness, scapular winging, foot drop | ||
| + | | complications = | ||
| + | | onset = Adolescence | ||
| + | | duration = Long term | ||
| + | | types = FSHD1, FSHD2 | ||
| + | | causes = Genetic (inherited or new mutation) | ||
| + | | risks = | ||
| + | | diagnosis = Genetic testing | ||
| + | | differential = [[Limb-girdle muscular dystrophy]] (especially LGMD2A), [[Pompe disease]], [[Mitochondrial myopathy]], [[Polymyositis]] | ||
| + | | prevention = | ||
| + | | management = Physical therapy, bracing, orthopedic surgery | ||
| + | | medication = | ||
| + | | prognosis = | ||
| + | | frequency = 1 in 8333 to 1 in 15000 | ||
| + | | deaths = | ||
}} | }} | ||